Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-005299
Filing Date
2015-11-12
Accepted
2015-11-12 06:32:31
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 542863
2 ex31-1.htm EX-31.1 10882
3 ex31-2.htm EX-31.2 10683
4 ex32-1.htm EX-32.1 7051
5 ex32-2.htm EX-32.2 7136
  Complete submission text file 0001493152-15-005299.txt   3212684

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20150930.xml EX-101.INS 479724
7 XBRL SCHEMA FILE cdxi-20150930.xsd EX-101.SCH 42364
8 XBRL CALCULATION FILE cdxi-20150930_cal.xml EX-101.CAL 49278
9 XBRL DEFINITION FILE cdxi-20150930_def.xml EX-101.DEF 146332
10 XBRL LABEL FILE cdxi-20150930_lab.xml EX-101.LAB 308797
11 XBRL PRESENTATION FILE cdxi-20150930_pre.xml EX-101.PRE 240951
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

EIN.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-181719 | Film No.: 151221304
SIC: 2834 Pharmaceutical Preparations